Maxx Chatsko

Maxx Chatsko


Maxx has been a contributor to since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent articles

Here's Why Amyris Is Soaring Today

The industrial biotech has punched its ticket to the cannabis party, but investors shouldn't get too excited just yet.

3 Things to Watch at Cameco in 2019

The uranium miner and fuel fabricator has battened down the hatches to weather dismal market fundamentals in recent years. Is this the year the efforts pay off?

Is Rigel Pharmaceuticals a Buy?

This small-cap stock had a rough 2018, but the company just launched its first drug product. Will it be enough to regain Wall Street's trust?

Is Cara Therapeutics a Buy?

The $600 million pharma company is working on a drug with estimated peak annual sales of $500 million.

3 Things to Watch for Alcoa in 2019

The industrial powerhouse expects the aluminum market to grow at its slowest pace since the Great Recession. What will that mean for the business?

3 Top Growth Stocks to Buy Right Now

Start the year off the right way by injecting some long-term growth potential into your portfolio with one (or all) of these stocks.